i
Characteristics of E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Patients
-
11 2020
-
-
Source: J Ark Med Soc. 117(5):110-112
[PDF-185.22 KB]
Details:
-
Alternative Title:J Ark Med Soc
-
Personal Author:
-
Description:During August-December 2019, 23 persons who received a diagnosis of e-cigarette, or vaping, product use-associated lung injury (EVALI) were reported to the Arkansas Department of Health (ADH); none died. Among Arkansas EVALI patients, most were aged <25 years and white; two-thirds were male. Approximately half of Arkansas EVALI patients were admitted to intensive care units. Among 18 patients who were interviewed, 61% reported using both nicotine and tetrahydrocannabinol in an e-cigarette, or vaping, device during the 90 days preceding illness onset. Clinicians should remain vigilant for EVALI and continue to report cases to ADH.
-
Subjects:
-
Source:
-
Pubmed ID:37179818
-
Pubmed Central ID:PMC10174092
-
Document Type:
-
Funding:
-
Volume:117
-
Issue:5
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
